Live Breaking News & Updates on Morphosys Agview

Stay updated with breaking news from Morphosys agview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MorphoSys AG: Invitation to MorphoSys' Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023

MorphoSys AG: Invitation to MorphoSys' Third Quarter and First Nine Months 2023 Financial Results Conference Call on November 16, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Eamonn Nolan , Julia Neugebauer , Morphosys Agview , Thomas Biegi , Exchange Commission , Conference Call , Morphosy Annual Report , Ihre Watchlist ,

MorphoSys AG: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting

MorphoSys AG: MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Tim Demuth , Morphosys Agview , Thomas Biegi , Julia Neugebauer , Eamonn Nolan , Lymphoma Society , Development Officer , Hilton Bayfront Hotel , Drug Administration , American Society Of Hematology , Constellation Pharmaceuticals Inc , Exchange Commission , Xencor Inc , American Society , Annual Meeting , Morphosys Chief Research , Myelofibrosis Symptom Assessment Form , Janus Kinase Inhibitor Treatment Na , Minimal Clinically Important Difference , Anchor Based Analysis , Diffuse Largeb Cell Lymphoma , World Use , Among Racial , Ethnic Minorities ,

MorphoSys AG: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023

MorphoSys AG: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Indiens Wirtschaft , Morphosys Agview , Kaitlyn Nealy , Jean Paul Kress , Julia Neugebauer , Thomas Biegi , Ihre Chancen , Exchange Commission , Gross Margin , Product Sales , Preliminary Gross Margin , Chief Executive Officer , Morphosy Annual Report , Der Indien , Die Highlights ,

MorphoSys AG: Invitation to MorphoSys' First Quarter 2023 Financial Results Conference Call on May 4, 2023

Conference Call AlertMUNICH, GERMANY / ACCESSWIRE / April 27, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the first quarter 2023 on May 3, 2023 at 10:00 pm CEST (09:00 pm BST ....

United States , Thomas Biegi , Eamonn Nolan , Morphosys Agview , Julia Neugebauer , Exchange Commission , Conference Call , Morphosy Annual Report ,

MorphoSys AG: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs

MUNICH, GERMANY / ACCESSWIRE / March 2, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the company will stop work and operations on its pre-clinical research programs to optimize its cost ....

United States , Dennis Riedl , Thomas Biegi , Julia Neugebauer , Eamonn Nolan , Jean Paul Kress , Morphosys Agview , Exchange Commission , Chief Executive Officer , Morphosy Annual Report , Investor Relations ,